BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10918183)

  • 21. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.
    Lubensky IA; Debelenko LV; Zhuang Z; Emmert-Buck MR; Dong Q; Chandrasekharappa S; Guru SC; Manickam P; Olufemi SE; Marx SJ; Spiegel AM; Collins FS; Liotta LA
    Cancer Res; 1996 Nov; 56(22):5272-8. PubMed ID: 8912868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
    Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene.
    Guru SC; Manickam P; Crabtree JS; Olufemi SE; Agarwal SK; Debelenko LV
    J Intern Med; 1998 Jun; 243(6):433-9. PubMed ID: 9681840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
    Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
    Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.
    Chakrabarti R; Srivatsan ES; Wood TF; Eubanks PJ; Ebrahimi SA; Gatti RA; Passaro E; Sawicki MP
    Genes Chromosomes Cancer; 1998 Jun; 22(2):130-7. PubMed ID: 9598800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism.
    Villablanca A; Wassif WS; Smith T; Höög A; Vierimaa O; Kassem M; Dwight T; Forsberg L; Du Q; Learoyd D; Jones K; Stranks S; Juhlin C; Teh BT; Carling T; Robinson B; Larsson C
    Eur J Endocrinol; 2002 Sep; 147(3):313-22. PubMed ID: 12213668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
    Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
    Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.
    Hessman O; Lindberg D; Skogseid B; Carling T; Hellman P; Rastad J; Akerström G; Westin G
    Cancer Res; 1998 Feb; 58(3):377-9. PubMed ID: 9458074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma.
    Debelenko LV; Swalwell JI; Kelley MJ; Brambilla E; Manickam P; Baibakov G; Agarwal SK; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Travis WD; Emmert-Buck MR
    Genes Chromosomes Cancer; 2000 May; 28(1):58-65. PubMed ID: 10738303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymic carcinoids in multiple endocrine neoplasia type 1.
    Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
    Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis.
    Pannett AA; Thakker RV
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4371-4. PubMed ID: 11549677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No evidence of germline mutation or somatic deletion of the MEN1 gene in a case of familial multiple endocrine neoplasia type 1 (MEN1).
    Namihira H; Sato M; Matsubara S; Ohye H; Bhuiyan M; Murao K; Takahara J
    Endocr J; 1999 Dec; 46(6):811-6. PubMed ID: 10724357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region.
    Manickam P; Guru SC; Debelenko LV; Agarwal SK; Olufemi SE; Weisemann JM; Boguski MS; Crabtree JS; Wang Y; Roe BA; Lubensky IA; Zhuang Z; Kester MB; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Emmert-Buck MR; Collins FS; Chandrasekharappa SC
    Hum Genet; 1997 Nov; 101(1):102-8. PubMed ID: 9385379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
    Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
    J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
    Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.